Fairfield, Bush & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$5.04K 162
2023
Q4
$5.04K Buy
+50
New +$4.96K ﹤0.01% 350
2023
Q3
Sell
-100
Closed -$9.46K 158
2023
Q2
$9.46K Buy
+100
New +$8.45K ﹤0.01% 328

Other funds holding CAH

Fairfield, Bush & Co's CAH Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 50 shares — an estimated $5.04K sold.

Fairfield, Bush & Co first reported a position in CAH in Q2 2023 and held it in 2 quarters. The position peaked at $9.46K in Q2 2023. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 50 Cardinal Health shares in Q1 2024, an estimated $5.04K.
  • Fairfield, Bush & Co first reported a position in Cardinal Health in Q2 2023 and held it in 2 quarters.
  • Fairfield, Bush & Co's Cardinal Health position peaked at $9.46K in Q2 2023.
  • 1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.